- Investing Ideas
- Taiwanese Healthcare Undervalued over 20% based on DCF
Taiwanese Healthcare Undervalued over 20% based on DCF
Results
10
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
10 companies
Pegavision
Market Cap: NT$25.0b
Manufactures and sells medical devices, and optical and precision instruments in Taiwan.
6491
NT$325.00
7D
0%
1Y
-1.2%
Universal Vision Biotechnology
Market Cap: NT$11.7b
Operates a chain of eye care clinics in Taiwan and China.
3218
NT$138.00
7D
6.2%
1Y
-33.2%
Bioteque
Market Cap: NT$8.0b
Manufactures and sells medical devices in Asia, South America, North America, and internationally.
4107
NT$115.00
7D
1.3%
1Y
-5.7%
Pacific Hospital Supply
Market Cap: NT$5.8b
Manufactures, processes, and sells medical devices in Taiwan.
4126
NT$79.80
7D
0.9%
1Y
-13.3%
CVC Technologies
Market Cap: NT$1.9b
Engages in the manufacturing, assembly, processing, and sale of various types of pharmaceutical packaging machines and soft capsule equipment worldwide.
4744
NT$35.95
7D
5.3%
1Y
69.6%
Medical Imaging
Market Cap: NT$1.8b
Offers imaging hospital equipment leasing and maintenance services in China.
6637
NT$67.50
7D
0.6%
1Y
-8.8%
Arich Enterprise
Market Cap: NT$1.4b
Engages in the marketing, promotion, and distribution of pharmaceuticals in Taiwan.
4173
NT$18.30
7D
1.7%
1Y
-24.7%
AViTA
Market Cap: NT$1.3b
Engages in the research, development, manufacturing, and sales of home healthcare products.
4735
NT$32.60
7D
5.5%
1Y
-12.4%
Level Biotechnology
Market Cap: NT$1.1b
Engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan.
3118
NT$33.50
7D
0.6%
1Y
-1.5%
Healthconn
Market Cap: NT$879.8m
Engages in the health services management in Taiwan and China.
6665
NT$19.40
7D
-5.8%
1Y
-23.8%